← Leaderboards
Craig Michael Horbinski
Northwestern University
$6,678,232
Attributed
$8,498,410
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–24$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,498,410 · 7
By mechanism
R01$5,367,934 · 3
P50$1,836,260 · 2
K08$857,198 · 1
P30$437,018 · 1
Top collaborators
- Justin D. Lathia5 shared
- Geoffrey T Swanson5 shared
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorTissuesCellsMolecularGenesBaseGliomaMutationIn VitroResearch PersonnelFundingMalignant Neoplasm Of BrainBrain NeoplasmsParaffin EmbeddingLaboratoriesComplexApoptosisSuccessBindingNew Therapeutic TargetMalignant NeoplasmsIn VivoAdultNeoplastic Cell
Grant awards (33)
Targeting IDH mutations to improve seizure control in glioma patients$419,486
R01 · FY2024 · NS · contact PI
Biospecimen Core$241,312
P50 · FY2024 · CA · contact PI
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma$191,979
R01 · FY2024 · NS · contact PI
Targeting IDH mutations to improve seizure control in glioma patients$432,460
R01 · FY2023 · NS · contact PI
Biospecimen Core$257,471
P50 · FY2023 · CA · contact PI
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma$197,916
R01 · FY2023 · NS · contact PI
Targeting IDH mutations to improve seizure control in glioma patients$432,460
R01 · FY2022 · NS · contact PI
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma$363,946
R01 · FY2022 · NS · contact PI
Biospecimen Core$241,797
P50 · FY2022 · CA · contact PI
Targeting IDH mutations to improve seizure control in glioma patients$427,577
R01 · FY2021 · NS · contact PI
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma$360,687
R01 · FY2021 · NS · contact PI
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy$345,625
R01 · FY2021 · NS · contact PI
Biospecimen Core$294,830
P50 · FY2021 · CA · contact PI
Targeting IDH mutations to improve seizure control in glioma patients$438,913
R01 · FY2020 · NS · contact PI
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma$374,932
R01 · FY2020 · NS · contact PI
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy$345,625
R01 · FY2020 · NS · contact PI
Biospecimen Core$277,445
P50 · FY2020 · CA · contact PI
Mouse Histology and Phenotyping Laboratory Shared Resource$136,765
P30 · FY2020 · CA · contact PI
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy$345,625
R01 · FY2019 · NS · contact PI
Biospecimen Core$267,848
P50 · FY2019 · CA · contact PI
Mouse Histology and Phenotyping Laboratory Shared Resource$136,765
P30 · FY2019 · CA · contact PI
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy$345,625
R01 · FY2018 · NS · contact PI
Biospecimen Core$255,557
P50 · FY2018 · CA · contact PI
Mouse Histology and Phenotyping Laboratory Shared Resource$139,482
P30 · FY2018 · CA · contact PI
Mouse Histology and Phenotyping Laboratory Shared Resource$8,621
P30 · FY2018 · CA · contact PI
Mouse Histology and Phenotyping Laboratory Shared Resource$8,489
P30 · FY2018 · CA · contact PI
Mouse Histology and Phenotyping Laboratory Shared Resource$6,896
P30 · FY2018 · CA · contact PI
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy$345,078
R01 · FY2017 · NS · contact PI
The Significance of Isocitrate Dehydrogenase Mutations in Gliomas$170,622
K08 · FY2015 · CA · contact PI
The Significance of Isocitrate Dehydrogenase Mutations in Gliomas$171,644
K08 · FY2014 · CA · contact PI
The Significance of Isocitrate Dehydrogenase Mutations in Gliomas$171,644
K08 · FY2013 · CA · contact PI
The Significance of Isocitrate Dehydrogenase Mutations in Gliomas$171,644
K08 · FY2012 · CA · contact PI
The Significance of Isocitrate Dehydrogenase Mutations in Gliomas$171,644
K08 · FY2011 · CA · contact PI